Youssef, A., Li, S., Bouberhan, S., Bregar, A., Mazina, V., Melamed, A. (2025). A comparative study of the real-world safety and effectiveness of metronomic cyclophosphamide and bevacizumab with or without pembrolizumab for recurrent ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5590